comparing the vaccine to a placebo. It's looking over time at who develops the infection. Once the study is finished you look at the proportion who get COVID-19 among those who got the vaccine and among those who didn't get the vaccine. ...
Under a normal timetable, the period for a vaccine to be available is at least 12 to 18 months, according to the World Health Organization, meaning the vaccine will not be developed until the end of the year or early next year. But given the trends worldwide, the first vac...
believed to be the key to containing the global pandemic. The US Food and Drug Administration believes a vaccine in the United States could be at least a year away, and the World Health Organisation (WHO) has said that it could take 12 to 18 months.这...
At 18 months into the COVID-19 pandemic, many of the direct and indirect effects of SARS-CoV-2 on people with diabetes have become clearer, but knowledge gaps remain, say epidemiologists. "COVID-19 has had a devastating effect on the population with diabetes, and conversely, the high preva...
"This is not going to be 'The Hunger Games,'" said Dr. Allison Arwady, Chicago's public health commissioner, referring to the chaotic early national rollout of adult vaccines nearly a year ago. Chicago expected to have nearly enough vaccine in just the first week for nearly half of its ...
Throughout the pandemic, the public has had massive information needs, both about risk to be infected, how to behave to avoid infection, and about vaccine effectiveness and side effects. Information about the pandemic on the internet and in the media has been overwhelming. In addition to scienti...
• Drug allergy: History of old drug allergy or newly developed drug allergy due to anti‑COVID‑19 drugs or COVID‑19 vaccine should be asked, as ignorance may lead to anaphylaxis or any other catastrophic event intraoperatively. ...
A health worker administers a dose of COVID-19 vaccine to Anna Lujza Honecz from Hungary at a vaccination site in Tsinghua University, Beijing, capital of China, April 3, 2021. (Xinhua/Chen Zhonghao) "I think the overall COVID policy was consistent and well carried out. I felt safe al...
BEIJING, June 1 (Xinhua) -- A China-developed intranasal vaccine against COVID-19 has shown to be safe and effective in early-stage human trials, according to a new study published in the journal The Lancet Respiratory Medicine. Compared with currently available COVID-19 vaccines that are adm...
The first vaccine could be ready in 18 months, so we have to do everything today using the available weapons to fight this virus, while preparing for the long-term. 第一个疫苗可能在18个月后才能投入使用。所以,在筹划长远安排的同时,...